Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytokine-Serotonin Interactions in Post-Stroke Depression
NCT00254020Phase 4Completed
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jun 2005
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of citalopram in major depressive disorder (MDD), sponsored by Sunnybrook Health Sciences Centre. Primary endpoints: Centre for Epidemiological Studies-Depression Scale at 12 weeks, Mini Mental State Examination at 12 weeks and 1 more. Started Jun 2005; status: completed.
02
Drugs
citalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00254020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00254020.